首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3474篇
  免费   90篇
  国内免费   26篇
  3590篇
  2023年   7篇
  2022年   34篇
  2021年   49篇
  2020年   17篇
  2019年   8篇
  2018年   11篇
  2017年   19篇
  2016年   255篇
  2015年   962篇
  2014年   1307篇
  2013年   83篇
  2012年   88篇
  2011年   83篇
  2010年   78篇
  2009年   46篇
  2008年   41篇
  2007年   34篇
  2006年   20篇
  2005年   56篇
  2004年   63篇
  2003年   28篇
  2002年   30篇
  2001年   35篇
  2000年   17篇
  1999年   20篇
  1998年   8篇
  1997年   13篇
  1996年   7篇
  1995年   6篇
  1994年   5篇
  1993年   19篇
  1992年   14篇
  1991年   12篇
  1990年   9篇
  1989年   16篇
  1988年   8篇
  1987年   3篇
  1986年   5篇
  1985年   5篇
  1984年   3篇
  1973年   3篇
  1966年   4篇
  1964年   2篇
  1960年   2篇
  1957年   6篇
  1956年   2篇
  1955年   2篇
  1954年   2篇
  1943年   2篇
  1925年   2篇
排序方式: 共有3590条查询结果,搜索用时 0 毫秒
31.
32.
自发性高血压大鼠血管α1肾上腺素受体亚型的改变   总被引:1,自引:0,他引:1  
韩启德  李金玲 《生理学报》1992,44(3):229-236
本工作在离体与整体条件下比较易卒中型自发性高血压(SHRSP)大鼠与WKY大鼠血管中α_1受体的两种亚型。在离体灌流的主动脉、肾动脉与肠系膜动脉,50μmol/L氯甲基可乐定(CEC)预温育30min可使α_1受体激动时引起的最大收缩张力在SHRSP与WKY大鼠分别降为对照时的31.4±8.3%与35.2±2.9%,68.4±8.2%与80.1±7.3%,68.4±6.3%与55.4±7.0%,两者间均无显著性差别。但10μmol/L硝苯吡啶对α_1受体收缩效应的阻断作用则在SHRSP大鼠大大超过WKY大鼠,最大收缩张力分别降为对照时的3.1±1.5%与56.5±4.8%(P<0.01),9.0±4.1%与23.6±3.5%(P<0.05),5.9±2.5%与28.0±0.8%(P<0.01)。整体动物实验也显示硝苯吡啶的降血压作用及对苯肾上腺素升血压效应的阻断作用在SHRSP大鼠都较WKY大鼠显著增强。离体主动脉a_1受体激动时的快速相与持续相收缩均主要由α_(1B)亚型激动引起,硝苯吡啶对快速相收缩的阻断作用在SHRSP与WKY大鼠无显著性差别,但对持续相收缩的阻断作用则在SHRSP大鼠显著强于WKY大鼠。上述结果提示SHRSP大鼠血管α_1受体两种亚型的分布没有显著改变,但α_(1B)受体激动时继发性细胞外Ca~(2+)进入的途径由非双氢吡啶敏感性钙通道转变为双氢吡啶敏感性钙通道。  相似文献   
33.
The formation of complexes between oncoproteins of DNA tumor viruses and the cellular protein p53 is thought to result in inactivation of the growth suppressor function of p53. In cells transformed by nononcogenic human adenovirus type 5 (Ad5), the 55-kDa protein encoded by E1B forms a stable complex with p53 and sequesters it in the cytoplasm. However, the homologous 54-kDa protein of highly oncogenic Ad12 does not detectably associate with p53. Yet in Ad12-transformed cells, p53 is metabolically stable, is present at high levels in the nucleus, and contributes to the oncogenicity of the cells. Such properties have previously been described for mutant forms of p53. Here, we show that stable p53 in Ad12-transformed cells is wild type rather than mutant and that stabilization of p53 is a direct consequence of the expression of the Ad12 E1B protein. We also compared the effects of the E1B proteins on transformation of rodent cells by different combinations of oncogenes. A synergistic interaction was observed for the gene encoding the 54-kDa E1B protein of Ad12 with myc plus ras oncogenes, resembling the effect of mutant p53 on myc plus ras. In contrast, the Ad5 55-kDa E1B protein strongly inhibited transformation by myc plus ras but stimulated transformation by E1A plus ras. The data are explained in terms of different interactions of the two E1B proteins with endogenous p53. The results suggest that in cultured rat cells, endogenous wild-type p53 plays an essential role in cell proliferation, even in the presence of myc plus ras. The dependence on p53 is lost, however, when the adenovirus E1A oncogene is present.  相似文献   
34.
35.
大鼠血小板中的神经肽Y及其对血管收缩的影响   总被引:20,自引:0,他引:20  
杨耀芳  杨丽华 《生理学报》1993,45(4):400-404
特异性放射免疫分析显示大鼠血小板与富血小板血浆(PRP)分别含NPY免疫活性物质90±16ng/10~7血小板与93±19ng/ml,大大高于普通血浆(1.2±0.1ng/ml)与贫血小板血浆(PPP)(1.7±0.3 ng/ml)中的含量(P<0.001)。血小板样品HPLC各馏分的NPY放免活性峰位与标准NPY的峰位相符。PRP经胶原最大程度聚集后,血小板内的NPY浓度降为34±5 ng/10~7血小板,而PPP中的NPY浓度则升高到26±4 ng/ml。1.6 ml PRP经胶原作用产生最大程度聚集,由此分离所得的PPP引起离体灌流大鼠尾动脉收缩,张力上升380±80 mg;上述PPP经NPY抗血清处理后引起尾动脉收缩的幅度显著减小(190±40 mg,P<0.001)。而1 nmol/L人工合成NPY并不引起血管收缩。结果表明大鼠血小板中含有大量NPY,在不可逆聚集时可以释放,释放的NPY可能参与血小板聚集时释放物质的缩血管效应。  相似文献   
36.
Speciation in monogonont rotifers   总被引:7,自引:4,他引:3  
Monogonont rotifers are cyclical parthenogens livingin limnic habitats with considerable seasonalvariation and often with island-like features. Theoccurrence of bisexual reproduction in these organismsmakes it feasible to define fields for generecombination, i.e. biological species. In thispaper, we analyze the structure of the diversity inmonogonont rotifers using several data sets: taxonomicand intraspecific diversity as reported inidentification keys, morphological variation reportedin ecological studies, and allozyme and matingbehavior patterns. Our analysis suggests that siblingspecies may be frequent in rotifers. Monogonontrotifers seem to meet conditions for an activespeciation, which might be particularly promoted byseasonal specialization and timing of bisexualreproduction.  相似文献   
37.
李贵山  梁妮 《蛇志》1991,3(4):4-5
本文选用金黄地鼠的微血管,利用显微高速摄影技术,放大微观流场和血细胞,连续地“冻结”短瞬间的变化状态,把物理图象呈现在胶片上,经图像分析和数据处理,从定性及定量方面研究血液微流变学,为生命科学和医学研究提供了又一种新的方法。  相似文献   
38.
39.
microRNAs (miRNAs) play essential roles in cardiogenesis. The altered expression of miRNAs can result in cardiac malformations by inducing abnormalities in the behavior of cardiac cells. However, the role of miR-10a in the regulation of cardiomyocyte progenitor cells (CMPCs) remains undetermined. In the present study, we found that up- or down-regulation of miR-10a inhibited or promoted the proliferation of human CMPCs, respectively, without affecting their differentiation toward cardiomyocytes. miR-10a bound to GATA6 directly and reduced GATA6 expression. Over-expression of GATA6 greatly attenuated the miR-10a-mediated inhibitory effect on the proliferation of human CMPCs. Thus, our results indicate that miR-10a could effectively modulate the proliferation of human CMPCs by targeting GATA6. The finding provides novel insights into the potency of miR-10a during heart development.  相似文献   
40.
We have previously shown that ristocetin, an activator of glycoprotein Ib/IX/V, induces release of soluble CD40 (sCD40) ligand via thromboxane (TX) A(2) production from human platelets. In the present study, we investigated the effect of antithrombin-III (AT-III), an anticoagulant, on the ristocetin-induced glycoprotein Ib/IX/V activation in human platelets. AT-III inhibited ristocetin-stimulated platelet aggregation. The ristocetin-induced production of 11-dehydro-TXB(2), a stable metabolite of TXA(2), and the release of sCD40 ligand were suppressed by AT-III. AT-III also reduced the ristocetin-stimulated secretion of platelet-derived growth factor (PDGF)-AB. AT-III failed to affect U46619-, a TXA(2) receptor agonist, induced levels of p38 mitogen-activated protein kinase phosphorylation or sCD40 ligand release. AT-III reduced the binding of SZ2, a monoclonal antibody to the sulfated sequence in the α-chain of glycoprotein Ib, to the ristocetin-stimulated platelets. These results strongly suggest that AT-III reduced ristocetin-stimulated release of sCD40 ligand due to inhibiting TXA(2) production in human platelets.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号